The expansion includes new fluorinated sugars and GMP-grade Poly(I:C), supporting glycoengineering, bioproduction, vaccine ...
Preparing pharma and biotech teams for continuous FDA inspection readiness, mock inspections and proactive regulatory risk ...
Standardised cell systems can reduce biological variability, but robust potency testing must also demonstrate accuracy, precision and linearity. ICH Q2(R2) provides the framework to establish this ana ...
A blister package integrity testing strategy should give QA evidence that is relevant, repeatable, and practical to review.
Alcami, a leading contract development and manufacturing organisation (CDMO), today announced the appointment of biologics ...
Personalised medicine has commercial promise, but delivering it on the packaging line is a significant challenge. At CPHI ...
Revenue and adjusted EBITDA rose significantly in the second quarter of 2026 compared to the first quarter of 2026, but ...
The agreement will see MedPharm support the transfer and commercial manufacture of an undisclosed branded speciality topical ...
Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to support strong cell growth ...
C2 Pharma has added brinzolamide to its ophthalmic API portfolio following completion of process validation and submission of ...
Most pharmaceutical companies have set ambitious decarbonisation targets, with supply-chain-related emissions accounting for ...
Shilpa Biologicals has launched SB HiMax, an integrated CDMO platform designed to take monoclonal antibodies from gene to GMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results